Related Experiment Video
Updated: Aug 19, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2
Claire Jacob1, Graeme S Cottrell, Daphne Gehringer
1Departments of Surgery and Physiology, University of California, San Francisco, California 94143-0660, USA.
Abstract:
Mechanisms that arrest G-protein-coupled receptor (GPCR) signaling prevent uncontrolled stimulation that could cause disease. Although uncoupling from heterotrimeric G-proteins, which transiently arrests signaling, is well described, little is known about the mechanisms that permanently arrest signaling. Here we reported on the mechanisms that terminate signaling by protease-activated receptor 2 (PAR(2)), which mediated the proinflammatory and nociceptive actions of proteases. Given its irreversible mechanism of proteolytic activation, PAR(2) is a model to study the permanent arrest of GPCR signaling. By immunoprecipitation and immunoblotting, we observed that activated PAR(2) was mono-ubiquitinated. Immunofluorescence indicated that activated PAR(2) translocated from the plasma membrane to early endosomes and lysosomes where it was degraded, as determined by immunoblotting. Mutant PAR(2) lacking intracellular lysine residues (PAR(2)Delta14K/R) was expressed at the plasma membrane and signaled normally but was not ubiquitinated. Activated PAR(2) Delta14K/R internalized but was retained in early endosomes and avoided lysosomal degradation. Activation of wild type PAR(2) stimulated tyrosine phosphorylation of the ubiquitin-protein isopeptide ligase c-Cbl and promoted its interaction with PAR(2) at the plasma membrane and in endosomes in an Src-dependent manner. Dominant negative c-Cbl lacking the ring finger domain inhibited PAR(2) ubiquitination and induced retention in early endosomes, thereby impeding lysosomal degradation. Although wild type PAR(2) was degraded, and recovery of agonist responses required synthesis of new receptors, lysine mutation and dominant negative c-Cbl impeded receptor ubiquitination and degradation and allowed PAR(2) to recycle and continue to signal. Thus, c-Cbl mediated ubiquitination and lysosomal degradation of PAR(2) to irrevocably terminate signaling by this and perhaps other GPCRs.
Insights
Mechanisms permanently arrest G-protein-coupled receptor (GPCR) signaling. Activated protease-activated receptor 2 (PAR2) is ubiquitinated and degraded via lysosomes, a process mediated by c-Cbl, to terminate signaling.
Area of Science:
- Cellular Biology
- Molecular Pharmacology
- Signal Transduction
Background:
- G-protein-coupled receptors (GPCRs) mediate diverse cellular functions.
- Mechanisms for transient GPCR signaling arrest (G-protein uncoupling) are known.
- Permanent arrest mechanisms for GPCR signaling remain largely uncharacterized.
Purpose of the Study:
- To elucidate the mechanisms responsible for the permanent termination of signaling by protease-activated receptor 2 (PAR2).
- To investigate the role of ubiquitination and lysosomal degradation in PAR2 signaling arrest.
- To identify key proteins involved in the irreversible inactivation of PAR2.
Main Methods:
- Immunoprecipitation and immunoblotting to detect PAR2 ubiquitination and degradation.
- Immunofluorescence microscopy to track PAR2 localization.
- Utilizing PAR2 mutants (PAR2Δ14K/R) and dominant-negative c-Cbl to assess protein function.
- Investigating Src-dependent signaling pathways.
Main Results:
- Activated PAR2 undergoes mono-ubiquitination and subsequent lysosomal degradation.
- PAR2 mutants lacking lysine residues are not ubiquitinated and avoid lysosomal degradation.
- c-Cbl ubiquitin ligase mediates PAR2 ubiquitination and lysosomal targeting in an Src-dependent manner.
- Inhibition of c-Cbl function prevents PAR2 degradation, allowing receptor recycling and sustained signaling.
Conclusions:
- c-Cbl-mediated ubiquitination and lysosomal degradation represent a key mechanism for the permanent arrest of PAR2 signaling.
- This pathway ensures the irreversible termination of protease-activated receptor signaling.
- These findings may offer insights into the termination mechanisms of other GPCRs.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
GPCR Desensitization
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Unfolded Protein Response
